Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240028/S002

WiSE (Wireless Stimulation of the Endocardium Technology) CRT System

EBR Systems, Inc. · Decision date Sep 3, 2025

FDA DECISIONP240028/S002

What did the FDA decide?

FDA records P240028/S002 as a supplement to PMA P240028, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 3, 2025.

FDA approval order statement

additional wire bonder equipment
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 3, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P240028/S002
Regulatory pathway
PMA supplement
Product code
SEG
Decision code
OK30
Decision date
Sep 3, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Leadless Cardiac Resynchronization Therapy (CRT).

Product code
SEG
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P240028/S002 received

    Application receipt date recorded by FDA.

  2. P240028/S002 · FDA decision

    30-Day Notice

  3. P240028/S003 · Related supplement

    WiSE (Wireless Stimulation of the Endocardium Technology) CRT System

  4. P240028/S004 · Related supplement

    WiSE (Wireless Stimulation of the Endocardium Technology) CRT System

  5. P240028/S006 · Related supplement

    WiSE (Wireless Stimulation of the Endocardium Technology) CRT System

Timeline entries are records held by MedtechLedger for P240028. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240028

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

EBR Systems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
480 Oakmead Pkwy., Sunnyvale, CA, 94085

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records